{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:55:10Z","timestamp":1793037310973,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"am","delay-in-days":265,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009744","name":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001438","name":"Accelerate Brain Cancer Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS099368"],"award-info":[{"award-number":["R01NS099368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbcan.2025.189300","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:26:54Z","timestamp":1742066814000},"page":"189300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Exosomes: Traversing the blood-brain barrier and their therapeutic potential in brain cancer"],"prefix":"10.1016","volume":"1880","author":[{"given":"Xiaopei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole","family":"Artz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Steindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Hingtgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Benson","family":"Satterlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189300_bb0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbcan.2025.189300_bb0010","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2006.09.012","article-title":"Brain cancer diagnosis and therapy with nanoplatforms","volume":"58","author":"Koo","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189300_bb0015","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/epi.13112","article-title":"Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors","volume":"56","author":"Ullrich","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbcan.2025.189300_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2025.189300_bb0025","article-title":"A living ex vivo platform for functional, personalized brain cancer diagnosis","volume":"4","author":"Mann","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2025.189300_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.148614","article-title":"Black phosphorus nanosheets inhibit glioblastoma cell migration and invasion through modulation of WNT\/\u03b2-catenin and NOTCH signaling pathways","volume":"481","author":"Xiong","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bbcan.2025.189300_bb0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood\u2013brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0040","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2025.189300_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bbcan.2025.189300_bb0050","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12951-022-01610-7","article-title":"Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches","volume":"20","author":"Mitusova","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0060","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/biom11081131","article-title":"Transportation of single-domain antibodies through the blood-brain barrier","volume":"11","author":"Ruiz-Lopez","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2025.189300_bb0065","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acs.bioconjchem.9b00085","article-title":"Harnessing exosomes for the development of brain drug delivery systems","volume":"30","author":"Zheng","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbcan.2025.189300_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10571-015-0280-9","article-title":"Exosomes as tools to suppress primary brain tumor, cell","volume":"36","author":"Katakowski","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0075","first-page":"55","article-title":"Function of exosomes in neurological disorders and brain tumors","volume":"2","author":"Xiao","year":"2021","journal-title":"Extracell. Vesicles Circul. Nucleic Acids"},{"key":"10.1016\/j.bbcan.2025.189300_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(81)90512-5","article-title":"Exfoliation of membrane ecto-enzymes in the form of micro-vesicles","volume":"645","author":"Trams","year":"1981","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.bbcan.2025.189300_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2016.02.037","article-title":"Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity","volume":"228","author":"Ferguson","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0090","first-page":"2007174","article-title":"A holistic review of the state-of-the-art microfluidics for exosome separation: An overview of the current status","volume":"17","author":"Ding","year":"2021","journal-title":"Existing Obstacles, and Future Outlook, Small"},{"key":"10.1016\/j.bbcan.2025.189300_bb0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0100","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1021\/pr200434y","article-title":"Identification of a conserved glycan signature for microvesicles","volume":"10","author":"Batista","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbcan.2025.189300_bb0105","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1002\/pmic.200900351","article-title":"ExoCarta: a compendium of exosomal proteins and RNA","volume":"9","author":"Mathivanan","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0115","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189300_bb0120","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189300_bb0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13287-023-03409-1","article-title":"Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury","volume":"14","author":"Zhong","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bbcan.2025.189300_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2024.06.048","article-title":"Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy","volume":"372","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0135","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.3390\/ijms15034142","article-title":"Exosomes derived from mesenchymal stem cells","volume":"15","author":"Yu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0140","first-page":"178","article-title":"Lipid, protein, and MicroRNA composition within mesenchymal stem cell-derived exosomes","volume":"20","author":"Deng","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189300_bb0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1208\/s12248-016-0015-y","article-title":"Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia cell-secreted exosome Nanovesicles for the treatment of brain Cancer","volume":"19","author":"Yang","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.bbcan.2025.189300_bb0150","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbcan.2025.189300_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2022.03.038","article-title":"Glioma-derived exosomes hijack the blood\u2013brain barrier to facilitate nanocapsule delivery via LCN2","volume":"345","author":"Yang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112505","article-title":"Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment","volume":"215","author":"Wang","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bbcan.2025.189300_bb0165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/acs.molpharmaceut.4c01227","article-title":"The Tumor-Derived Exosomes Enhanced Bevacizumab across the Blood\u2013Brain Barrier for Antiangiogenesis Therapy against Glioblastoma","volume":"22","author":"Chu","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2025.189300_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.715461","article-title":"The biogenesis, biological functions, and applications of macrophage-derived exosomes","volume":"8","author":"Shan","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0175","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ymthe.2017.02.007","article-title":"Exosomes from M1-polarized macrophages potentiate the Cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node","volume":"25","author":"Cheng","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0180","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ymthe.2022.10.008","article-title":"Cell-derived nanovesicle-mediated drug delivery to the brain: principles and strategies for vesicle engineering","volume":"31","author":"Liang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12951-024-02298-7","article-title":"Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2018.10.004","article-title":"Recent progress of drug nanoformulations targeting to brain","volume":"291","author":"Khan","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0195","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbcan.2025.189300_bb0200","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","article-title":"Efficient RNA drug delivery using red blood cell extracellular vesicles","volume":"9","author":"Usman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189300_bb0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2019.02.011","article-title":"Milk exosomes - natural nanoparticles for siRNA delivery","volume":"449","author":"Aqil","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189300_bb0210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes\u2013vesicular carriers for intercellular communication","volume":"21","author":"Simons","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molmed.2014.04.003","article-title":"The role of extracellular vesicles in the progression of neurodegenerative disease and cancer","volume":"20","author":"Candelario","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189300_bb0220","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41583-020-0322-2","article-title":"Neuronal regulation of the blood-brain barrier and neurovascular coupling","volume":"21","author":"Kaplan","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0225","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1007\/s12035-021-02324-x","article-title":"Stem cell-derived exosomes: a new strategy of neurodegenerative disease treatment","volume":"58","author":"Fayazi","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood\u2013brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbcan.2025.189300_bb0235","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.2174\/1381612823666170913164738","article-title":"The transport mechanism of extracellular vesicles at the blood-brain barrier","volume":"23","author":"Matsumoto","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbcan.2025.189300_bb0240","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1039\/C9NR01255A","article-title":"Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the tau protein through the AKT\/GSK-3\u03b2 pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbcan.2025.189300_bb0245","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jconrel.2022.08.002","article-title":"Overcoming the blood-brain barrier: exosomes as theranostic nanocarriers for precision neuroimaging","volume":"349","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0250","doi-asserted-by":"crossref","first-page":"2101090","DOI":"10.1002\/advs.202101090","article-title":"Development of novel therapeutics targeting the blood\u2013brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","article-title":"P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis","volume":"22","author":"Tylawsky","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbcan.2025.189300_bb0260","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cells9040851","article-title":"Targeting and crossing the blood-brain barrier with extracellular vesicles","volume":"9","author":"Saint-Pol","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189300_bb0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/pharmaceutics13010122","article-title":"Unlocking the power of exosomes for crossing biological barriers in drug delivery","volume":"13","author":"Elliott","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.011","article-title":"Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain","volume":"142","author":"Yuan","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0275","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.12.03","article-title":"The role of exosomes in tumor immunity","volume":"6","author":"Yang","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189300_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232442","article-title":"Plasma-derived exosome-like vesicles are enriched in lyso-phospholipids and pass the blood-brain barrier","volume":"15","author":"Jakubec","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189300_bb0285","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189300_bb0290","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41419-021-04004-z","article-title":"TGF-beta1-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p\/EPB41L5 axis to promote non-small cell lung cancer brain metastasis","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189300_bb0295","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","article-title":"Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis","volume":"13","author":"Morad","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2025.189300_bb0300","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2022.03.038","article-title":"Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2","volume":"345","author":"Yang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0305","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0310","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/ejn.14974","article-title":"Heparan sulfate proteoglycan-mediated dynamin-dependent transport of neural stem cell exosomes in an in vitro blood-brain barrier model","volume":"53","author":"Joshi","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0320","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/acs.molpharmaceut.8b00985","article-title":"Cluster of differentiation 46 is the major receptor in human blood-brain barrier endothelial cells for uptake of exosomes derived from brain-metastatic melanoma cells (SK-Mel-28)","volume":"16","author":"Kuroda","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2025.189300_bb0325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-mediated metastasis: communication from a distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2025.189300_bb0330","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fimmu.2014.00442","article-title":"Tetraspanins in extracellular vesicle formation and function","volume":"5","author":"Andreu","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0335","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2015.03.004","article-title":"From zero to six double bonds: phospholipid unsaturation and organelle function","volume":"25","author":"Antonny","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0340","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-3495(01)75695-0","article-title":"The influence of Lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes","volume":"81","author":"Fuller","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbcan.2025.189300_bb0345","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003148","article-title":"Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments","volume":"9","author":"Bhatta","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189300_bb0350","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jcp.10333","article-title":"Endothelial cell functions","volume":"196","author":"Michiels","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0355","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/cr.2017.71","article-title":"Remote control of BBB: a tale of exosomes and microRNA","volume":"27","author":"Zhao","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2025.189300_bb0360","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/cr.2017.62","article-title":"Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity","volume":"27","author":"Xu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2025.189300_bb0365","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189300_bb0370","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbrc.2018.05.140","article-title":"Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier","volume":"502","author":"Zhao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189300_bb0375","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/ncomms3123","article-title":"Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma","volume":"4","author":"Grapp","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189300_bb0380","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40259-020-00434-x","article-title":"Designer exosomes: a new platform for biotechnology therapeutics","volume":"34","author":"Jafari","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.bbcan.2025.189300_bb0385","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4155\/tde.13.21","article-title":"Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells","volume":"4","author":"Duf\u00e8s","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bbcan.2025.189300_bb0390","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0395","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0400","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbcan.2025.189300_bb0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-024-02414-7","article-title":"Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.bbcan.2025.189300_bb0410","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","article-title":"Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes","volume":"317","author":"Kim","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0415","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/pharmaceutics14030672","article-title":"Strategies for targeted delivery of exosomes to the brain: advantages and challenges","volume":"14","author":"Choi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0420","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bc500291r","article-title":"Surface functionalization of exosomes using click chemistry","volume":"25","author":"Smyth","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbcan.2025.189300_bb0425","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1021\/acs.bioconjchem.0c00216","article-title":"In situ one-step fluorescence labeling strategy of exosomes via bioorthogonal click chemistry for real-time exosome tracking in vitro and in vivo","volume":"31","author":"Song","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbcan.2025.189300_bb0430","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4103\/1673-5374.284982","article-title":"Engineering mesenchymal stromal\/stem cell-derived extracellular vesicles with improved targeting and therapeutic efficiency for the treatment of central nervous system disorders","volume":"15","author":"Iavorovschi","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbcan.2025.189300_bb0435","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1021\/acsami.7b18135","article-title":"Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma Multiforme","volume":"10","author":"Ye","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbcan.2025.189300_bb0440","doi-asserted-by":"crossref","first-page":"eaba3967","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson's disease","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2025.189300_bb0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/ijms21010181","article-title":"Intranasally administered human MSC-derived extracellular vesicles pervasively incorporate into neurons and microglia in both intact and status epilepticus injured forebrain","volume":"21","author":"Kodali","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0450","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/stem.3456","article-title":"Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases","volume":"39","author":"Herman","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2025.189300_bb0455","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0460","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0465","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.3390\/ijms21124407","article-title":"Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation","volume":"21","author":"Banks","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0470","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","article-title":"Elucidation of exosome migration across the blood-brain barrier model in vitro","volume":"9","author":"Chen","year":"2016","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.bbcan.2025.189300_bb0475","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2020.06.036","article-title":"Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges","volume":"113","author":"Mehryab","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2025.189300_bb0480","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1021\/acs.molpharmaceut.3c00620","article-title":"Nanodrug delivery strategies to signaling pathways in alopecia","volume":"20","author":"Wu","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2025.189300_bb0485","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0490","first-page":"L110","article-title":"Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo","volume":"312","author":"Zhang","year":"2017","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.bbcan.2025.189300_bb0495","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/pharmaceutics13111870","article-title":"Exosome-mediated insulin delivery for the potential treatment of diabetes mellitus","volume":"13","author":"Rodr\u00edguez-Morales","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0500","doi-asserted-by":"crossref","DOI":"10.3791\/58814","article-title":"Preparation of exosomes for siRNA delivery to cancer cells","author":"Faruqu","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbcan.2025.189300_bb0505","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/mt.2016.126","article-title":"Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing","volume":"24","author":"Didiot","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0510","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomed.: Nanotechnol Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189300_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12163","article-title":"Active cargo loading into extracellular vesicles: highlights the heterogeneous encapsulation behaviour","volume":"10","author":"Chen","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bbcan.2025.189300_bb0520","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers13030380","article-title":"Circulating Exosomal integrin beta3 is associated with intracranial failure and survival in lung Cancer patients receiving cranial irradiation for brain metastases: a prospective observational study","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189300_bb0525","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","article-title":"Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins","volume":"205","author":"Fuhrmann","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0530","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2020.06.036","article-title":"Exosomes as a next-generation drug delivery system: an update on drug loading approaches, characterization, and clinical application challenges","volume":"113","author":"Mehryab","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2025.189300_bb0535","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biomaterials.2017.05.003","article-title":"High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy","volume":"135","author":"Gao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0540","doi-asserted-by":"crossref","first-page":"1900042","DOI":"10.1002\/mabi.201900042","article-title":"Mannose-modified serum exosomes for the elevated uptake to murine dendritic cells and lymphatic accumulation","volume":"19","author":"Choi","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0545","first-page":"1499","article-title":"Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy","volume":"13","author":"Cao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2025.189300_bb0550","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","article-title":"Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations","volume":"14","author":"Kim","year":"2018","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189300_bb0555","doi-asserted-by":"crossref","first-page":"1900163","DOI":"10.1002\/biot.201900163","article-title":"Targeted exosomes for drug delivery: biomanufacturing, surface tagging, and validation","volume":"15","author":"Si","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bbcan.2025.189300_bb0560","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.ymthe.2018.05.024","article-title":"Optimized cholesterol-siRNA chemistry improves productive loading onto extracellular vesicles","volume":"26","author":"Haraszti","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0565","doi-asserted-by":"crossref","first-page":"1807189","DOI":"10.1002\/adfm.201807189","article-title":"Light-inducible exosome-based vehicle for endogenous RNA loading and delivery to leukemia cells","volume":"29","author":"Huang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bbcan.2025.189300_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00675-6","article-title":"Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis","volume":"18","author":"Yan","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0575","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.gene.2015.08.067","article-title":"Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases","volume":"575","author":"Xitong","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2025.189300_bb0580","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1074\/jbc.M114.621383","article-title":"Stabilization of exosome-targeting peptides via engineered glycosylation","volume":"290","author":"Hung","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189300_bb0585","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","article-title":"A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties","volume":"29","author":"Dooley","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0590","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2016.02.058","article-title":"Development of exosome surface display technology in living human cells","volume":"472","author":"Stickney","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189300_bb0595","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/sji.12072","article-title":"Generation of soluble NKG 2 D ligands: proteolytic cleavage, exosome secretion and functional implications","volume":"78","author":"Chitadze","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0600","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/immu.200310028","article-title":"Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59","volume":"33","author":"Clayton","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0605","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.29803","article-title":"Hepatic stellate cell\u2013derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2","volume":"68","author":"Kostallari","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2025.189300_bb0610","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1016\/j.vaccine.2011.09.133","article-title":"Increasing vaccine potency through exosome antigen targeting","volume":"29","author":"Hartman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bbcan.2025.189300_bb0615","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2147\/IJN.S133430","article-title":"Pseudotyping exosomes for enhanced protein delivery in mammalian cells","volume":"12","author":"Meyer","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2025.189300_bb0620","doi-asserted-by":"crossref","first-page":"1440131","DOI":"10.1080\/20013078.2018.1440131","article-title":"Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery","volume":"7","author":"Yang","year":"2018","journal-title":"J. Extracell Vesicles"},{"key":"10.1016\/j.bbcan.2025.189300_bb0625","article-title":"Exosomes based strategies for brain drug delivery","volume":"121949","author":"Rehman","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0630","article-title":"Enhanced brain delivery and antiproliferative activity of resveratrol using milk-derived exosomes","volume":"18","author":"\u00c1vila-G\u00e1lvez","year":"2024","journal-title":"J. Agric. Food Res."},{"key":"10.1016\/j.bbcan.2025.189300_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2024.104888","article-title":"Loading milk exosomes with urolithins boosts their delivery to the brain: comparing the activity of encapsulated vs. free urolithins in SH-SY5Y neuroblastoma cells","volume":"61","author":"\u00c1vila-G\u00e1lvez","year":"2024","journal-title":"Food Biosci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0640","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12951-023-02006-x","article-title":"Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood\u2013brain-barrier penetration and tumor microenvironment modulation","volume":"21","author":"Kim","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0645","first-page":"13","article-title":"Exosomes in cancer: use them or target them?, Semin cell","volume":"78","author":"Bastos","year":"2018","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0650","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2025.189300_bb0655","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acs.molpharmaceut.8b00901","article-title":"Exosome as a novel shuttle for delivery of therapeutics across biological barriers","volume":"16","author":"Das","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2025.189300_bb0660","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1134\/S1819712418030030","article-title":"Exosome Drug Delivery through the Blood\u2013Brain Barrier: Experimental Approaches and Potential Applications","volume":"12","author":"Druzhkova","year":"2018","journal-title":"Neurochem. J."},{"key":"10.1016\/j.bbcan.2025.189300_bb0665","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.omtn.2021.12.029","article-title":"Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells","volume":"27","author":"Adamus","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbcan.2025.189300_bb0670","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5405","article-title":"Neural stem cellderived exosomes transfer miR1243p into cells to inhibit glioma growth by targeting FLOT2","volume":"61","author":"Qian","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.60","article-title":"Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma Multiforme cells conferred Chemosensitivity","volume":"2","author":"Munoz","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbcan.2025.189300_bb0680","article-title":"Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model","volume":"23","author":"Nooshabadi","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbcan.2025.189300_bb0685","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/membranes12010085","article-title":"Targeted delivery of exosomes armed with anti-cancer therapeutics","volume":"12","author":"Choi","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.bbcan.2025.189300_bb0690","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189300_bb0695","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2022.03.038","article-title":"Glioma-derived exosomes hijack the blood\u2013brain barrier to facilitate nanocapsule delivery via LCN2","volume":"345","author":"Yang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0700","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0705","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biomaterials.2018.05.048","article-title":"Development and MPI tracking of novel hypoxia-targeted theranostic exosomes","volume":"177","author":"Jung","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0710","doi-asserted-by":"crossref","unstructured":"H. Choi, Y. Choi, H.Y. Yim, A. Mirzaaghasi, J.-K. Yoo, C. Choi, biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng. Regen. Med. 18 (2021) 499\u2013511.","DOI":"10.1007\/s13770-021-00361-0"},{"key":"10.1016\/j.bbcan.2025.189300_bb0715","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","article-title":"Tumor-Derived Extracellular Vesicles Breach the Intact Blood\u2013Brain Barrier via Transcytosis","volume":"13","author":"Morad","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2025.189300_bb0720","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2022.02.020","article-title":"Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment","volume":"86","author":"Srivastava","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0725","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.2147\/IJN.S263956","article-title":"Inhibition of glioma Cells' proliferation by doxorubicin-loaded exosomes via microfluidics","volume":"15","author":"Thakur","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2025.189300_bb0730","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","article-title":"Biodistribution and delivery efficiency of unmodified tumor-derived exosomes","volume":"199","author":"Smyth","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0735","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0740","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/neuonc\/noac071","article-title":"Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy","volume":"24","author":"Zhan","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0745","doi-asserted-by":"crossref","first-page":"14576","DOI":"10.1021\/acsami.9b00893","article-title":"Ultrasound facilitates naturally equipped exosomes derived from macrophages and blood serum for Orthotopic glioma treatment","volume":"11","author":"Bai","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbcan.2025.189300_bb0750","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-022-00894-3","article-title":"Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189300_bb0755","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/cphc.201701198","article-title":"Brain-cortex microglia-derived exosomes: nanoparticles for glioma therapy","volume":"19","author":"Murgoci","year":"2018","journal-title":"Chemphyschem"},{"key":"10.1016\/j.bbcan.2025.189300_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0765","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189300_bb0770","doi-asserted-by":"crossref","first-page":"1801899","DOI":"10.1002\/advs.201801899","article-title":"Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0775","article-title":"Overcoming the blood-brain barrier by using a multistage exosome delivery system to inhibit central nervous system lymphoma","volume":"41","author":"Liu","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbcan.2025.189300_bb0780","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/acs.langmuir.1c02500","article-title":"Membrane-decorated exosomes for combination drug delivery and improved glioma therapy","volume":"38","author":"Liang","year":"2022","journal-title":"Langmuir"},{"key":"10.1016\/j.bbcan.2025.189300_bb0785","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1039\/D1BM01723C","article-title":"Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3","volume":"10","author":"Liang","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0790","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3389\/fonc.2020.01453","article-title":"The antitumor effect of gene-engineered exosomes in the treatment of brain metastasis of breast Cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189300_bb0795","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2024.06.048","article-title":"Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy","volume":"372","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0800","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1021\/acsnano.5b06939","article-title":"Blood exosomes endowed with magnetic and targeting properties for cancer therapy","volume":"10","author":"Qi","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2025.189300_bb0805","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0810","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/cphc.201701198","article-title":"Brain-cortex microglia-derived exosomes: nanoparticles for glioma therapy","volume":"19","author":"Murgoci","year":"2018","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.bbcan.2025.189300_bb0815","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.xphs.2017.02.030","article-title":"Pharmacokinetics of exosomes\u2014An important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics","volume":"106","author":"Morishita","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbcan.2025.189300_bb0820","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","article-title":"Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood-brain barrier penetration","volume":"9","author":"Khongkow","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189300_bb0825","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","article-title":"A review on exosomes application in clinical trials: perspective, questions, and challenges","volume":"20","author":"Rezaie","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2025.189300_bb0830","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2021.07.004","article-title":"Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: a head-to-head comparison","volume":"336","author":"Wu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2025.189300_bb0835","doi-asserted-by":"crossref","first-page":"eabg6666","DOI":"10.1126\/sciadv.abg6666","article-title":"Bottom-up assembly of biomedical relevant fully synthetic extracellular vesicles","volume":"7","author":"Staufer","year":"2021","journal-title":"Sci. Adv."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:24:55Z","timestamp":1778214295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":167,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0304419X25000423"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189300","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes: Traversing the blood-brain barrier and their therapeutic potential in brain cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189300"}}